Pharmacopeia (PCOP) Reduces Workforce by 28%
More News related to PCOP
- Pharmacopeia (PCOP) Reduces Workforce by 28%
- Pharmacopeia (PCOP) Tops Q3 View By 20c
- Trading Radar for 11/06: Disney (DIS), Anheuser-Busch (BUD), NVIDIA (NVDA), Nasdaq (NDAQ), Toyota (TM), Priceline.com (PCLN) Reports; Initial Jobless Claims, Preliminary Productivity for Q3 Due
- Rodman & Renshaw Downgrades Pharmacopeia (PCOP) to Market Perform
- Unusual 11 Mid-Day Movers 9/25: TOPS, FRE, FNM, PCOP Higher; AMN, CRAI, PPC, MTN Lower
In a Form 8-K, Pharmacopeia (Nasdaq: PCOP) announced that on December 19, 2008, it reduced its workforce by approximately 28% through termination of positions. The Company notified the 22 affected employees of their termination dates, all of which will be as of January 2, 2009. Substantially all of the severance cost is expected to result in future cash expenditures.
Pharmacopeia, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs.
Related Categories
Corporate NewsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
